This Briefer details the early dynamics of the outbreak, evaluates the testing, vaccination, and therapeutic rollout, and provides an outlook and analysis meant to help the United States prevent and address similar biological threats.

This Briefer details the early dynamics of the outbreak, evaluates the testing, vaccination, and therapeutic rollout, and provides an outlook and analysis meant to help the United States prevent and address similar biological threats.